• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

(312) 726-2699 | Attorney Referrals

Latest News: $1.4 Million for Malpractice Death

Napleton & Partners

Napleton & Partners

  • About
    • About Us
    • FAQs
  • Attorneys
    • Robert J. Napleton
    • Daniel T. Madigan
    • Bradley Z. Schulman
    • Brion W. Doherty
    • David J. Gallagher
    • Brian C. Fetzer
    • John T. Goldrick
    • Patrick J. Giese
    • Ryan A. Scott
    • L. Michael Tarpey
    • Rory J. Cannon
    • Nicholas J. Motherway of Counsel
  • Practice Areas
    • Medical Negligence
    • Auto Accidents
    • Truck Accidents
    • Products Liability
    • Birth Injury
    • Premises Liability
    • Nursing Home
    • Wrongful Death
  • Case Results
  • News & Developments
    • News & Developments
    • Client Testimonials
  • Contact Us
A close-up of a government or institutional building with classical architecture facade with rows of tall, stone columns.

Appellate Court Rules in Favor of Patient Who Took Generic Darvocet

In 2010, Lewis Guvenoz was given a prescription for the generic version of Darvocet just months before the Food and Drug Administration pulled the drug from the market for a high risk of heart arrhythmias.  While taking the drug as prescribed, Guvenoz suffered cardiac arrest that caused serious brain injuries and ultimately his death.

His wife, Nicole Guvenoz, filed a lawsuit in Cook County Circuit Court against Teva Pharmaceuticals USA Inc. and Target corp., whose Batavia pharmacy dispensed the prescription.

Guvenoz contended Teva and Target should not have marketed or sold the drug in the first place – once they knew the drug product was unsafe.

In a 34-page opinion written by 1st District Appellate Justice Robert E. Gordon, the panel found that the facts in the current case are different enough from those in the U.S. Supreme Court’s 2011 Mensing ruling and its 2013 Bartlett ruling that federal pre-emption does not apply.

“In the case at bar, plaintiff alleges that there was no group of patients for whom the drug’s benefits outweighed its risks,” Gordon wrote.  “By contrast, in both Bartlett and Mensing, the drug was safe for the vast majority of patients taking it, and only a ‘very small number of patients suffered an adverse and severe reaction.’”

Because the drug was banned by the FDA, there was no issue whether Teva and Target should have stopped selling the drug.

“They should have, and they did,” Gordon wrote.  “However, defendants argue that federal law provided them with a safe harbor for failing to stop earlier.  Unfortunately for defendants, the Bartlett court has already rejected that idea.”

The panel ruled that federal law would pre-empt the negligence claim over altering the drug warnings – but that was not what Guvenoz alleged.

The Appellate Court also found that federal law requiring generic drugs to be the same as their name-brand equivalent does not shield generic manufacturers from strict-liability claims when they sell a drug that fails to perform as expected or has high risks that outweigh benefits.

Guvenoz was represented by Robert J. Napleton and Bradley Z. Schulman.


Category: Products LiabilityTag: Bradley Z. Schulman, Robert J. Napleton

Sidebar

  • Category

Archives

  • September 2025
  • August 2025
  • May 2025
  • April 2025
  • January 2025
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • June 2024
  • March 2024
  • February 2024
  • January 2024
  • July 2023
  • April 2023
  • February 2023
  • December 2022
  • June 2022
  • March 2022
  • December 2021
  • August 2021
  • May 2021
  • March 2021
  • February 2021
  • January 2021
  • October 2020
  • September 2020
  • July 2020
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • November 2018
  • June 2018
  • May 2018
  • November 2017
  • October 2017
  • March 2017
  • February 2017
  • November 2016
  • April 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • April 2015
  • February 2015
  • December 2014
  • November 2014
  • May 2014
  • March 2014
  • January 2014
  • December 2013
  • November 2013
  • January 2013
  • December 2012
  • June 2012
  • May 2012
  • January 2012
  • December 2011
  • October 2010
  • August 2010
  • March 2010
  • December 2009
  • August 2009
  • June 2009
  • May 2009
  • March 2009
  • January 2009
  • August 2008
  • April 2008
  • October 2007
  • September 2007
  • June 2007
  • March 2007
  • October 2006
  • August 2006
  • February 2006
  • December 2005
  • May 2005
  • April 2005
  • December 2004
  • August 2003
  • June 2003
  • January 2003
  • December 2002
  • October 2002
  • August 2002
  • May 2002
  • March 2002
  • January 2002
  • December 2001
  • October 2001
  • May 2001
  • March 2001
  • February 2001
  • August 2000
  • May 2000
  • March 2000
  • January 1999

Categories

  • Auto Accident
  • Birth Injury
  • Client Testimonials
  • Medical Negligence
  • News
  • Premises Liability
  • Products Liability
  • Truck Accident
  • Wrongful Death

Ready to Get Started?

Contact us today for a no-cost consultation and speak with an experienced personal injury and wrongful death trial lawyer about your potential case. Learn whether you have a case and if we can help you or your family.

Contact Us
An award logo from an organization called America's Top 100 Attorneys.
  • Home
  • News & Developments
  • About
  • Attorneys
  • Practice Areas
  • Case Results
  • Client Testimonials
  • FAQs
  • Referrals
  • Contact
Logo for American Board of Trial Advocates.

Find Us on Facebook

firm@rjnlawoffice.com
(312) 726-2699

140 South Dearborn St #1500
Chicago, IL 60603

Copyright © 2025 · Napleton & Partners · All Rights Reserved